Click here to get full coverage on If EPS Growth Is Important To You, Rigel Pharmaceuticals (NASDAQ:RIGL) Presents An Opportunity - simplywall.st

If EPS Growth Is Important To You, Rigel Pharmaceuticals (NASDAQ:RIGL) Presents An Opportunity  simplywall.st

If EPS Growth Is Important To You, Rigel Pharmaceuticals (NASDAQ:RIGL) Presents An Opportunity - simplywall.st

Click here to get full coverage on Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update  PR Newswire

Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Click here to get full coverage on Rigel Pharma: Q3 Earnings Showcase Robust Growth (NASDAQ:RIGL) - Seeking Alpha

Rigel Pharma: Q3 Earnings Showcase Robust Growth (NASDAQ:RIGL)  Seeking Alpha

Rigel Pharma: Q3 Earnings Showcase Robust Growth (NASDAQ:RIGL) - Seeking Alpha

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance - Yahoo Finance

Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance  Yahoo Finance

Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? - sharewise.com

Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue?  sharewise.com

Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? - sharewise.com

Click here to get full coverage on Rigel Pharmaceuticals (Nasdaq: RIGL) plans Dec. 3 talk at Piper Sandler conference - Stock Titan

Rigel Pharmaceuticals (Nasdaq: RIGL) plans Dec. 3 talk at Piper Sandler conference  Stock Titan

Rigel Pharmaceuticals (Nasdaq: RIGL) plans Dec. 3 talk at Piper Sandler conference - Stock Titan

Click here to get full coverage on Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference - Eastern Progress

Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference  Eastern Progress

Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference - Eastern Progress

Click here to get full coverage on Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference - Sahm

Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference  Sahm

Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference - Sahm

Click here to get full coverage on Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL) - Seeking Alpha

Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL)  Seeking Alpha

Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL) - Seeking Alpha

Click here to get full coverage on Rigel to Present at the Jefferies Global Healthcare Conference in London - PR Newswire

Rigel to Present at the Jefferies Global Healthcare Conference in London  PR Newswire

Rigel to Present at the Jefferies Global Healthcare Conference in London - PR Newswire

Click here to get full coverage on Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Report Preview: What to Expect - Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Report Preview: What to Expect  Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Report Preview: What to Expect - Yahoo Finance

Click here to get full coverage on Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition - PR Newswire

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition  PR Newswire

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition - PR Newswire

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Profitability Rebound Reinforces Bullish Valuation Narratives - Yahoo Finance

Rigel Pharmaceuticals (RIGL) Profitability Rebound Reinforces Bullish Valuation Narratives  Yahoo Finance

Rigel Pharmaceuticals (RIGL) Profitability Rebound Reinforces Bullish Valuation Narratives - Yahoo Finance

Click here to get full coverage on Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update  PR Newswire

Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Click here to get full coverage on Rigel Pharmaceuticals (RIGL): Assessing Valuation Following Record Q3 Results and Raised 2025 Outlook - Yahoo Finance

Rigel Pharmaceuticals (RIGL): Assessing Valuation Following Record Q3 Results and Raised 2025 Outlook  Yahoo Finance

Rigel Pharmaceuticals (RIGL): Assessing Valuation Following Record Q3 Results and Raised 2025 Outlook - Yahoo Finance

Click here to get full coverage on Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology - PR Newswire

Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology  PR Newswire

Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology - PR Newswire

Click here to get full coverage on Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update  PR Newswire

Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Click here to get full coverage on Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS - PR Newswire

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS  PR Newswire

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS - PR Newswire

Click here to get full coverage on Surging Earnings Estimates Signal Upside for Rigel (RIGL) Stock - Yahoo Finance

Surging Earnings Estimates Signal Upside for Rigel (RIGL) Stock  Yahoo Finance

Surging Earnings Estimates Signal Upside for Rigel (RIGL) Stock - Yahoo Finance

Click here to get full coverage on What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)? - Yahoo Finance

What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)?  Yahoo Finance

What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)? - Yahoo Finance

Click here to get full coverage on RIGL vs. FOLD: Which Biotech Stock Offers Better Growth Potential? - Yahoo Finance

RIGL vs. FOLD: Which Biotech Stock Offers Better Growth Potential?  Yahoo Finance

RIGL vs. FOLD: Which Biotech Stock Offers Better Growth Potential? - Yahoo Finance

Click here to get full coverage on Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner  Yahoo Finance

Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35% - simplywall.st

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35%  simplywall.st

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35% - simplywall.st

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Turns Profitable, But Guidance for Earnings Decline Challenges Bullish Narratives - simplywall.st

Rigel Pharmaceuticals (RIGL) Turns Profitable, But Guidance for Earnings Decline Challenges Bullish Narratives  simplywall.st

Rigel Pharmaceuticals (RIGL) Turns Profitable, But Guidance for Earnings Decline Challenges Bullish Narratives - simplywall.st

Click here to get full coverage on Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality - Yahoo Finance

Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality  Yahoo Finance

Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run?  Yahoo Finance

Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Click here to get full coverage on All You Need to Know About Rigel (RIGL) Rating Upgrade to Strong Buy - Yahoo Finance

All You Need to Know About Rigel (RIGL) Rating Upgrade to Strong Buy  Yahoo Finance

All You Need to Know About Rigel (RIGL) Rating Upgrade to Strong Buy - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Price Target Increased by 11.74% to 43.69 - Nasdaq

Rigel Pharmaceuticals (RIGL) Price Target Increased by 11.74% to 43.69  Nasdaq

Rigel Pharmaceuticals (RIGL) Price Target Increased by 11.74% to 43.69 - Nasdaq

Click here to get full coverage on Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - PR Newswire

Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update  PR Newswire

Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - PR Newswire

Click here to get full coverage on What Makes Rigel Pharmaceuticals (RIGL) a Strong Momentum Stock: Buy Now? - Nasdaq

What Makes Rigel Pharmaceuticals (RIGL) a Strong Momentum Stock: Buy Now?  Nasdaq

What Makes Rigel Pharmaceuticals (RIGL) a Strong Momentum Stock: Buy Now? - Nasdaq

Click here to get full coverage on Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ... - Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ...  Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ... - Yahoo Finance

Click here to get full coverage on Jefferies Upgrades Rigel Pharmaceuticals (RIGL) - Nasdaq

Jefferies Upgrades Rigel Pharmaceuticals (RIGL)  Nasdaq

Jefferies Upgrades Rigel Pharmaceuticals (RIGL) - Nasdaq

Click here to get full coverage on H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT - Yahoo Finance

H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT  Yahoo Finance

H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT - Yahoo Finance

Click here to get full coverage on Eli Lilly Partner And Cancer Treatment Maker Nears Buy Point - Investor's Business Daily

Eli Lilly Partner And Cancer Treatment Maker Nears Buy Point  Investor's Business Daily

Eli Lilly Partner And Cancer Treatment Maker Nears Buy Point - Investor's Business Daily

Click here to get full coverage on Why analysts upgrade RIGL stock - Weekly Trend Recap & Stock Market Timing Techniques - moha.gov.vn

Why analysts upgrade RIGL stock - Weekly Trend Recap & Stock Market Timing Techniques  moha.gov.vn

Why analysts upgrade RIGL stock - Weekly Trend Recap & Stock Market Timing Techniques - moha.gov.vn

Click here to get full coverage on Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35% - Sahm

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35%  Sahm

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35% - Sahm

Click here to get full coverage on Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance

Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out?  Yahoo Finance

Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Report Preview: What To Look For - Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Report Preview: What To Look For  Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Report Preview: What To Look For - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals (RIGL): Valuation Insights After Raised 2025 Guidance and Q3 Performance - Sahm

Rigel Pharmaceuticals (RIGL): Valuation Insights After Raised 2025 Guidance and Q3 Performance  Sahm

Rigel Pharmaceuticals (RIGL): Valuation Insights After Raised 2025 Guidance and Q3 Performance - Sahm

Click here to get full coverage on Institutional Investors Control 85% of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) and Were Rewarded Last Week After Stock Increased 10% - 富途牛牛

Institutional Investors Control 85% of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) and Were Rewarded Last Week After Stock Increased 10%  富途牛牛

Institutional Investors Control 85% of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) and Were Rewarded Last Week After Stock Increased 10% - 富途牛牛

Click here to get full coverage on H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL) - Yahoo Finance

H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL)  Yahoo Finance

H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL) - Yahoo Finance

Click here to get full coverage on Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? - Nasdaq

Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock?  Nasdaq

Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? - Nasdaq

Click here to get full coverage on H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - 富途牛牛

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57  富途牛牛

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - 富途牛牛

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Is Up 14.2% After Raising 2025 Revenue Guidance on Strong Q3 Results - simplywall.st

Rigel Pharmaceuticals (RIGL) Is Up 14.2% After Raising 2025 Revenue Guidance on Strong Q3 Results  simplywall.st

Rigel Pharmaceuticals (RIGL) Is Up 14.2% After Raising 2025 Revenue Guidance on Strong Q3 Results - simplywall.st

Click here to get full coverage on Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Call Highlight - GuruFocus

Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Call Highlight  GuruFocus

Rigel Pharmaceuticals Inc (RIGL) Q3 2025 Earnings Call Highlight - GuruFocus

Click here to get full coverage on Do Options Traders Know Something About RIGL Stock We Don't? - Nasdaq

Do Options Traders Know Something About RIGL Stock We Don't?  Nasdaq

Do Options Traders Know Something About RIGL Stock We Don't? - Nasdaq

Click here to get full coverage on How Rigel Pharmaceuticals’ R289 Trial Progress and FDA Designations Will Impact RIGL Investors - Yahoo Finance

How Rigel Pharmaceuticals’ R289 Trial Progress and FDA Designations Will Impact RIGL Investors  Yahoo Finance

How Rigel Pharmaceuticals’ R289 Trial Progress and FDA Designations Will Impact RIGL Investors - Yahoo Finance

Click here to get full coverage on After Plunging 28% in 4 Weeks, Here's Why the Trend Might Reverse for Rigel (RIGL) - Yahoo Finance

After Plunging 28% in 4 Weeks, Here's Why the Trend Might Reverse for Rigel (RIGL)  Yahoo Finance

After Plunging 28% in 4 Weeks, Here's Why the Trend Might Reverse for Rigel (RIGL) - Yahoo Finance

Click here to get full coverage on Voya Strengthens Position in Rigel Pharmaceuticals, Inc. (RIGL) - Yahoo Finance

Voya Strengthens Position in Rigel Pharmaceuticals, Inc. (RIGL)  Yahoo Finance

Voya Strengthens Position in Rigel Pharmaceuticals, Inc. (RIGL) - Yahoo Finance

Click here to get full coverage on Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now? - Yahoo Finance

Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now?  Yahoo Finance

Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now? - Yahoo Finance

Click here to get full coverage on Earnings Estimates Moving Higher for Rigel (RIGL): Time to Buy? - Nasdaq

Earnings Estimates Moving Higher for Rigel (RIGL): Time to Buy?  Nasdaq

Earnings Estimates Moving Higher for Rigel (RIGL): Time to Buy? - Nasdaq

Click here to get full coverage on Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion (NASDAQ:RIGL) - Seeking Alpha

Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion (NASDAQ:RIGL)  Seeking Alpha

Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion (NASDAQ:RIGL) - Seeking Alpha

Click here to get full coverage on Rigel Pharmaceuticals (RIGL): Valuation Insights After Raised 2025 Guidance and Q3 Performance - simplywall.st

Rigel Pharmaceuticals (RIGL): Valuation Insights After Raised 2025 Guidance and Q3 Performance  simplywall.st

Rigel Pharmaceuticals (RIGL): Valuation Insights After Raised 2025 Guidance and Q3 Performance - simplywall.st

Click here to get full coverage on Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? - Yahoo Finance

Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now?  Yahoo Finance

Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? - Yahoo Finance

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research

Rigel Pharmaceuticals (RIGL) Just Flashed Golden Cross Signal: Do You Buy?  Zacks Investment Research

Rigel Pharmaceuticals (RIGL) Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research

Click here to get full coverage on Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Newswire

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress  PR Newswire

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Newswire

Click here to get full coverage on Rigel Provides Business Update and 2025 Outlook - PR Newswire

Rigel Provides Business Update and 2025 Outlook  PR Newswire

Rigel Provides Business Update and 2025 Outlook - PR Newswire

Click here to get full coverage on Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...  Yahoo Finance

Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Click here to get full coverage on RIGL: Commercial expansion and pipeline advances drive profitability and future growth - TradingView

RIGL: Commercial expansion and pipeline advances drive profitability and future growth  TradingView

RIGL: Commercial expansion and pipeline advances drive profitability and future growth - TradingView

Click here to get full coverage on Jefferies Upgrades RIGL Rating to "Buy" and Raises Price Target to $42 | RIGL Stock News - GuruFocus

Jefferies Upgrades RIGL Rating to "Buy" and Raises Price Target to $42 | RIGL Stock News  GuruFocus

Jefferies Upgrades RIGL Rating to "Buy" and Raises Price Target to $42 | RIGL Stock News - GuruFocus

Click here to get full coverage on Why Rigel (RIGL) Could Beat Earnings Estimates Again - Nasdaq

Why Rigel (RIGL) Could Beat Earnings Estimates Again  Nasdaq

Why Rigel (RIGL) Could Beat Earnings Estimates Again - Nasdaq

Click here to get full coverage on Rigel Pharmaceuticals (RIGL) Set for Q3 Earnings Announcement - GuruFocus

Rigel Pharmaceuticals (RIGL) Set for Q3 Earnings Announcement  GuruFocus

Rigel Pharmaceuticals (RIGL) Set for Q3 Earnings Announcement - GuruFocus

Click here to get full coverage on Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout - Seeking Alpha

Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout  Seeking Alpha

Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout - Seeking Alpha

Click here to get full coverage on Rigel Pharmaceuticals (NASDAQ: RIGL) raises 2025 revenue outlook; net income $27.9M - Stock Titan

Rigel Pharmaceuticals (NASDAQ: RIGL) raises 2025 revenue outlook; net income $27.9M  Stock Titan

Rigel Pharmaceuticals (NASDAQ: RIGL) raises 2025 revenue outlook; net income $27.9M - Stock Titan

Click here to get full coverage on Rigel Pharmaceuticals jumps on 2025 revenue guidance boost, Q3 beats - Seeking Alpha

Rigel Pharmaceuticals jumps on 2025 revenue guidance boost, Q3 beats  Seeking Alpha

Rigel Pharmaceuticals jumps on 2025 revenue guidance boost, Q3 beats - Seeking Alpha

Click here to get full coverage on Can RIGL's Oncology Portfolio Create Long-Term Value Beyond Tavalisse? - Nasdaq

Can RIGL's Oncology Portfolio Create Long-Term Value Beyond Tavalisse?  Nasdaq

Can RIGL's Oncology Portfolio Create Long-Term Value Beyond Tavalisse? - Nasdaq

Click here to get full coverage on Does Rigel Pharmaceuticals (NASDAQ:RIGL) Have A Healthy Balance Sheet? - simplywall.st

Does Rigel Pharmaceuticals (NASDAQ:RIGL) Have A Healthy Balance Sheet?  simplywall.st

RIGL

Price Chart

Key Statistics

Technicals

About RIGL

Latest News

If EPS Growth Is Important To You, Rigel Pharmaceuticals (NASDAQ:RIGL) Presents An Opportunity - simplywall.st

Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Rigel Pharma: Q3 Earnings Showcase Robust Growth (NASDAQ:RIGL) - Seeking Alpha

Advanced Charts

Top Gainers

Top Losers